Establishment of AlpaRET
Filed with ASX · · 15 pages · English
Earlier from Nova Eye Medical
- FY20 Results presentation
- FY 20 Results
- Full Year Statutory Accounts
- Australian Tax Office Class Ruling on Capital Gain
- Acquisition of Molteno Ophthalmology Assets
Later from Nova Eye Medical
- Sales Update
- Half Year Results Discussion
- Investor presentation Half year Results 31 December 2020
- Clinical trial to Assess Efficacy and Safety of i Track
- 2RT Post LEAD Review Shows Improved Treatment Benefits
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical